Validation and Compliance

May 01, 2013
BioPharm International
Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
Apr 01, 2013
BioPharm International
EU authorities are stepping up their efforts to incorporate QbD principles.
Apr 01, 2013
BioPharm International
Opioid abuse generates calls for efforts to curb distribution.
Apr 01, 2013
BioPharm International
By BioPharm International Editors
Latin America's diverse growing market seeks regulatory harmonization.
Apr 01, 2013
BioPharm International
By BioPharm International Editors
Have FDA initiatives improved manufacturing quality?
Mar 02, 2013
BioPharm International
By BioPharm International Editors
The authors present solutions based on a review of current service offerings and their audit experience.
Mar 02, 2013
BioPharm International
By BioPharm International Editors
This article examines the options to best match needs and spending for quality and regulatory leadership.
Mar 01, 2013
BioPharm International
Discussions are underway as the pharmaceutical sector calls for greater consistency in the global monitoring of GMP compliance and quality testing of APIs and finished medicines.
Mar 01, 2013
BioPharm International
By BioPharm International Editors
USP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
Mar 01, 2013
BioPharm International
Vaccine development is benefiting from manufacturing advances.
native1_300x100
lorem ipsum